# OnCo record diffusing-alpha-emitter-radiotherapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/diffusing-alpha-emitter-radiotherapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "diffusing-alpha-emitter-radiotherapy" ;
  schema:name "Diffusing alpha-emitter radiation therapy (Alpha DaRT)"@en ;
  schema:alternateName "Alpha DaRT"@en, "Diffusing alpha-emitters radiation therapy"@en, "Intratumoural diffusing alpha emitters"@en ;
  schema:description "Thin metal sources carrying radium-224 are placed inside a solid tumour. As the radium decays, short-lived radioactive atoms leave the source, spread a few millimetres through the tumour and give off alpha particles, a radiation that does heavy damage over a very short distance. The human evidence so far is small studies with no comparison group."@en ;
  schema:url <https://onco.cc/technologies/diffusing-alpha-emitter-radiotherapy/> ;
  schema:dateModified "2026-11-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1088/0031-9155/52/16/021>, <https://doi.org/10.1016/j.ijrobp.2019.10.048>, <https://doi.org/10.1093/neuonc/noag189.402>, <https://www.sec.gov/Archives/edgar/data/1871321/000121390026120072/ea031236301ex99-1.htm>, <https://clinicaltrials.gov/study/NCT06910306> ;
  onco:status "emerging" ;
  onco:tag "alpha-emitter", "device" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:sections <https://onco.cc/fronts/radiation/> ;
  onco:technologies <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/> ;
  onco:companies <https://onco.cc/companies/alpha-tau-medical/> ;
  onco:institutions <https://onco.cc/institutions/tel-aviv-university/> ;
  onco:trials <https://onco.cc/trials/regain-alpha-dart/> .
